What experts think Rejuran

What Experts Think About Rejuran: Science, Results, and Real-World Applications

Dermatologists and aesthetic practitioners widely regard Rejuran as a groundbreaking solution for skin repair and rejuvenation, with clinical studies showing a 92% patient satisfaction rate in improving acne scars and skin texture. This polynucleotide-based injectable, derived from salmon DNA, has gained traction in 23 countries since its 2016 FDA approval in South Korea. Let’s dissect why medical experts increasingly recommend this treatment over traditional options like hyaluronic acid fillers or laser therapies.

The Science Behind Rejuran’s Effectiveness

Rejuran contains polydeoxyribonucleotide (PDRN) fragments measuring 500-800 base pairs – the optimal size for cellular absorption according to 2023 research in the Journal of Cosmetic Dermatology. These fragments work through three primary mechanisms:

Dr. Emma Richardson, a London-based dermatologist with 15 years’ experience, notes: “What sets Rejuran apart is its dual action – it repairs existing damage while creating a biological environment for ongoing skin improvement.” This explains why 78% of patients in a 2022 multicenter study maintained results for 18+ months with proper maintenance.

Clinical Performance Across Skin Concerns

Data from 4,372 patients across 14 clinics shows significant variation in effectiveness by condition:

• Acne scars: 2.3 point improvement on Goodman & Baron scale after 3 sessions
• Fine lines: 89% reduction in wrinkle depth (measured via 3D imaging)
• Skin hydration: 62% increase in corneometer readings
• Pore size: 34% reduction observed at 6-month follow-up

Notably, a 2023 split-face study comparing Rejuran to microneedling showed superior results:

Practical Considerations for Patients

While Rejuran shows promise, experts at Rejuran emphasize these key factors:

1. Treatment Protocol: Most patients require 3-4 sessions at 4-week intervals
2. Cost Efficiency: Average $600-$900 per session vs $1,200-$1,800 for equivalent laser packages
3. Combination Therapies: 82% better results when paired with radiofrequency vs standalone use
4. Safety Profile: 0.3% incidence of adverse effects vs 2.1% for HA fillers (2023 Aesthetic Surgery Journal data)

Dr. Michael Tan from Singapore’s National Skin Center cautions: “While generally safe, patients with fish allergies or active skin infections should avoid Rejuran until properly assessed.” His clinic’s data shows 97% complication-free outcomes when following proper screening protocols.

Market Adoption and Professional Endorsements

The global Rejuran market reached $287 million in 2023, growing at 14.2% CAGR according to Grand View Research. Professional endorsements break down as:

• 84% of surveyed US dermatologists recommend it for mature skin
• 67% of Korean plastic surgeons prefer it over HA for scar revision
• 58% of UK aesthetic practitioners report increased demand post-COVID

Dr. Laura Chen from UCLA Medical Center explains this popularity: “In our practice, Rejuran addresses two major pandemic-era concerns – mask-related acne and accelerated skin aging from stress. Patients appreciate its natural-looking results without facial volume distortion.”

Future Developments and Limitations

While current data is promising, researchers are working to improve Rejuran’s formulation. A 2024 pilot study testing vitamin C-infused PDRN showed:

• 42% faster healing time
• 31% better melanin reduction
• 19% higher patient satisfaction

However, limitations remain. The same study noted 22% variability in results depending on injection technique, emphasizing the need for skilled practitioners. Dr. Raj Patel from Harvard Medical School states: “We’re excited about Rejuran’s potential but need more long-term data – particularly regarding its cumulative effects over 5+ years of use.”